387 related articles for article (PubMed ID: 8550066)
1. Alloantigen presentation by B cells: analysis of the requirement for B-cell activation.
Wilson JL; Cunningham AC; Kirby JA
Immunology; 1995 Nov; 86(3):325-30. PubMed ID: 8550066
[TBL] [Abstract][Full Text] [Related]
2. Hybrid cells formed by fusion of Epstein-Barr virus-associated B-lymphoblastoid cells and either marrow-derived or solid tumour-derived cell lines display different co-stimulatory phenotypes and abilities to activate allogeneic T-cell responses in vitro.
Cywinski AL; Dunnion DJ; Teobald I; Tucker VC; Browning MJ
Tissue Antigens; 2006 Aug; 68(2):115-26. PubMed ID: 16866881
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of enhanced antigen presentation by B cells activated with anti-mu plus interferon-gamma: role of B7-2 in the activation of naive and memory CD4+ T cells.
Morokata T; Kato T; Igarashi O; Nariuchi H
Eur J Immunol; 1995 Jul; 25(7):1992-8. PubMed ID: 7542599
[TBL] [Abstract][Full Text] [Related]
4. Proliferation of human T lymphocytes induced with superantigens is not dependent on costimulation by the CD28 counter-receptor B7.
Damle NK; Klussman K; Leytze G; Linsley PS
J Immunol; 1993 Feb; 150(3):726-35. PubMed ID: 7678619
[TBL] [Abstract][Full Text] [Related]
5. The immunogenic potential of human fetal retinal pigment epithelium and its relation to transplantation.
Rezai KA; Semnani RT; Patel SC; Ernest JT; van Seventer GA
Invest Ophthalmol Vis Sci; 1997 Nov; 38(12):2662-71. PubMed ID: 9375586
[TBL] [Abstract][Full Text] [Related]
6. Induction of melanoma antigen-specific cytotoxic T lymphocytes in vitro by stimulation with B7-expressing human melanoma cell lines.
Fenton RG; Turcovski-Corrales SM; Taub DD
J Immunother; 1998 Mar; 21(2):95-108. PubMed ID: 9551360
[TBL] [Abstract][Full Text] [Related]
7. The capacity of the natural ligands for CD28 to drive IL-4 expression in naïve and antigen-primed CD4+ and CD8+ T cells.
Bian Y; Hiraoka S; Tomura M; Zhou XY; Yashiro-Ohtani Y; Mori Y; Shimizu J; Ono S; Dunussi-Joannopoulos K; Wolf S; Fujiwara H
Int Immunol; 2005 Jan; 17(1):73-83. PubMed ID: 15569772
[TBL] [Abstract][Full Text] [Related]
8. B7 costimulatory molecules from malignant cells in patients with b-cell chronic lymphoproliferative disorders trigger t-cell proliferation.
Trentin L; Perin A; Siviero M; Piazza F; Facco M; Gurrieri C; Galvan S; Adami F; Agostini C; Pizzolo G; Zambello R; Semenzato G
Cancer; 2000 Sep; 89(6):1259-68. PubMed ID: 11002221
[TBL] [Abstract][Full Text] [Related]
9. The B7 adhesion molecule is expressed on activated human T cells: functional involvement in T-T cell interactions.
Wyss-Coray T; Mauri-Hellweg D; Baumann K; Bettens F; Grunow R; Pichler WJ
Eur J Immunol; 1993 Sep; 23(9):2175-80. PubMed ID: 7690323
[TBL] [Abstract][Full Text] [Related]
10. Selective antigen presenting activity of cortical thymic epithelial cells against CD4+ T cells associated with both lack of costimulatory molecules and inefficient presentation of MHC-peptide ligands.
Kaneda R; Iwabuchi K; Kasai M; Murakami M; Uede T; Onoé K
Cell Immunol; 1997 Nov; 181(2):163-71. PubMed ID: 9398403
[TBL] [Abstract][Full Text] [Related]
11. CD40-stimulated B lymphocytes pulsed with tumor antigens are effective antigen-presenting cells that can generate specific T cells.
Lapointe R; Bellemare-Pelletier A; Housseau F; Thibodeau J; Hwu P
Cancer Res; 2003 Jun; 63(11):2836-43. PubMed ID: 12782589
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of biliary epithelium: investigation of antigen presentation to CD4+ T cells.
Leon MP; Bassendine MF; Wilson JL; Ali S; Thick M; Kirby JA
Hepatology; 1996 Sep; 24(3):561-7. PubMed ID: 8781325
[TBL] [Abstract][Full Text] [Related]
13. Direct helper T cell-induced B cell differentiation involves interaction between T cell antigen CD28 and B cell activation antigen B7.
Damle NK; Linsley PS; Ledbetter JA
Eur J Immunol; 1991 May; 21(5):1277-82. PubMed ID: 1645270
[TBL] [Abstract][Full Text] [Related]
14. Activated B cells express CD28/B7-independent costimulatory activity.
Ding L; Shevach EM
J Immunol; 1996 Aug; 157(4):1389-96. PubMed ID: 8759718
[TBL] [Abstract][Full Text] [Related]
15. Expression and functional analysis of murine B7 delineated by a novel monoclonal antibody.
Powers GD; Faherty DA; Connaughton SE; Biondi DA; Godfrey DI; Gault A; Chen CY; Nabavi N
Cell Immunol; 1994 Feb; 153(2):298-311. PubMed ID: 7509723
[TBL] [Abstract][Full Text] [Related]
16. Differential ability of fixed antigen-presenting cells to stimulate nominal antigen-reactive and alloreactive T4 lymphocytes.
Moreno J; Lipsky PE
J Immunol; 1986 May; 136(10):3579-87. PubMed ID: 3084635
[TBL] [Abstract][Full Text] [Related]
17. Requirement of Ia-positive accessory cells in the MLR response against class II antigen on human B cell tumor line.
Yamamoto M; Yano A
J Immunol; 1985 Dec; 135(6):3887-96. PubMed ID: 2999233
[TBL] [Abstract][Full Text] [Related]
18. Surface immunoglobulins are involved in the interaction of protein A with human B cells and in the triggering of B cell proliferation induced by protein A-containing Staphylococcus aureus.
Romagnani S; Giudizi MG; Biagiotti R; Almerigogna F; Maggi E; Del Prete G; Ricci M
J Immunol; 1981 Oct; 127(4):1307-13. PubMed ID: 6974188
[TBL] [Abstract][Full Text] [Related]
19. Expression and function of B7 on human epidermal Langerhans cells.
Symington FW; Brady W; Linsley PS
J Immunol; 1993 Feb; 150(4):1286-95. PubMed ID: 7679425
[TBL] [Abstract][Full Text] [Related]
20. Functional characterization of a novel anti-B7 monoclonal antibody.
de Boer M; Parren P; Dove J; Ossendorp F; van der Horst G; Reeder J
Eur J Immunol; 1992 Dec; 22(12):3071-5. PubMed ID: 1280221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
